Irritable Bowel Syndrome Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Irritable Bowel Syndrome (IBS) based on a specific set of medical guidelines called the Rome IV criteria, which means having recurring stomach pain at least one day per week on average over the last 3 months, linked to two or more of the following: pain that is related to going to the toilet, changes in how often a person has bowel movements, or changes in the appearance of stools — with these symptoms starting at least 6 months before diagnosis.
- People aged between 18 and 75 years.
- People who are able to understand and speak Dutch.
- People who are able to understand how to use a smartphone or app-based survey tool called the ESM application.
Who may not be able to join:
- People who have had abdominal (stomach area) surgery in the past, with the exception of certain straightforward procedures such as an appendix removal, keyhole gallbladder removal, or hysterectomy — or as otherwise decided by the lead researcher.
- People who have metal implants or devices in their body, such as metal joint replacements, pacemakers, metal clips on blood vessels, metal fragments in the eye, certain intrauterine devices (IUDs) — the Mirena IUD is excepted — metal braces, facial tattoos, or other metal objects in the body.
- People with a history of serious head injury or surgery on the head or brain.
- People with a history of claustrophobia (fear of enclosed spaces).
- People who are pregnant, breastfeeding, or planning to become pregnant during the study period.
- Students or employees of Maastricht University who have a direct personal, professional, or supervisory relationship with any member of the study team or their department (confirm with trial site).
- People with a heart rhythm condition (cardiac arrhythmia) may require approval from their own doctor before the trial site can confirm participation.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Daniel Keszthelyi, Maastricht University
Phone: 0883887808
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Clinical meaningful decrease in severity of GI-symptoms
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.